Celltrion Pharm Inc. Logo

Celltrion Pharm Inc.

Manufactures and supplies chemical pharmaceuticals and biosimilar products.

068760 | KO

Overview

Corporate Details

ISIN(s):
KR7068760008
LEI:
Country:
South Korea
Address:
충청북도 청주시 청원구 오창읍 2산단로 82셀트리온제약, 청주시

Description

Celltrion Pharm Inc. is a pharmaceutical company specializing in the manufacturing and supply of chemical pharmaceuticals and biosimilar products. The company's portfolio includes treatments for various conditions, with a notable focus on biosimilars for autoimmune diseases. A key product is Remsima, a biosimilar of Infliximab, indicated for treating rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis. As an integral part of the global biopharmaceutical company Celltrion, Celltrion Pharm distributes its products to both domestic and international markets, contributing to the accessibility of advanced biologic therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 8.9 KB
2025-08-14 00:00
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 2.6 MB
2025-06-23 00:00
[기재정정]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 135.3 KB
2025-05-30 00:00
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 100.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.4 MB
2025-05-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB
2025-04-10 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-04-10 00:00
주식등의대량보유상황보고서(일반)
Korean 252.0 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all Celltrion Pharm Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celltrion Pharm Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celltrion Pharm Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.